According to its corporate purpose the company is engaged in acquiring and managing equity participations and in the development, manufacture, marketing and sale of analytical instruments, consumables and services. AB Sciex Germany GmbH markets, supports and services mass spectrometers in Germany for application areas such as biomarker testing, clinical diagnostics, clinical research, drug development, environmental and food testing and forensics. The company has no production or R&D activities in Germany but serves as the headquarters for marketing, sales and supporting functions for the EMEAI region and hosts the largest product demonstration laboratory of the AB Sciex group in Germany. Revenues were generated exclusively in Germany and the company is 100% owned by DH Acquisition Holding GmbH (Danaher group).
Erwerb von Beteiligungen an anderen Unternehmen, Verwaltung dieser Beteiligungen, Entwicklung, Herstellung und Vermarktung sowie Verkauf von analytischen Instrumenten, Verbrauchsgütern und Dienstleistungen sowie verwandte Produkte und Dienstleistungen
Converted using the official Destatis and Eurostat correspondence tables; ISIC Rev. 4 is the United Nations' international industry classification.
This summary was generated with the help of AI. See our Data Quality Notice. Report error?
Source: German Commercial Register (Handelsregister) Darmstadt Local Court, HRB 88376 (as of 1 November 2026)
| Name | Type | City |
|---|---|---|
| Michael Cowhig | Geschäftsführer(in) | 02494 Needham, Massachusetts |
| Klaus Sauber | Geschäftsführer(in) | Karlsbad |
| Yang Xue | Geschäftsführer(in) | Berkel en Rodenrijs |
Source: German Commercial Register (Handelsregister) Darmstadt Local Court, HRB 88376 (as of 1 November 2026)
| Date | Event Type | Event |
|---|---|---|
| 22.09.2010 | Business Address Change | Landwehrstraße 54, 64293 Darmstadt |
| 03.05.2010 | Business Address Change | Frankfurter Straße 129 b, 64293 Darmstadt |
| 20.11.2009 | Company Name Registered | AB Sciex Germany GmbH |
| Date | Type | Change | Total Capital |
|---|---|---|---|
| 20.11.2009 | Share Capital Set | — | 25.000 € |
| Date | Contract | Value |
|---|---|---|
| 5.11.2026 | Supplier · Medizinische Universität Lausitz - Carl Thiem KdöR | — |
| 5.10.2026 | Supplier · Land Berlin, vertreten durch die Senatsverwaltung für Wissenschaft, Gesundheit und Pflege | 428.738 € |
| 25.9.2026 | Beschaffung eines Massenspektrometers (LC/MS/MS) für die die FILK Freiberg Institute gGmbH Supplier · FILK Freiberg Institute gGmbH | 491.355 € |
Source: German Commercial Register (Handelsregister) Darmstadt Local Court, HRB 88376 (as of 1 November 2026)
| Year | Revenue | Profit | Balance | Employees |
|---|---|---|---|---|
| 2025 | €66,470,573 | €6,916,605 | €34,713,778 | — |
| 2024 | €62,909,990 | €6,547,726 | €30,810,028 | — |
| 2023 | €69,615,587 | €5,361,943 | €31,530,271 | — |
| 2022 | €70,451,075 | €4,918,517 | €33,423,662 | — |
| 2021 | €63,152,496 | €2,784,191 | €28,493,859 | — |
| 2020 | €60,103,015 | €2,886,335 | €33,368,765 | — |
| 2019 | €56,813,303 | €3,098,247 | €29,179,241 | — |
| 2018 | €66,257,199 | €2,189,722 | €23,384,076 | — |
| 2017 | €72,291,866 | €2,176,728 | €27,753,157 | — |
| 2016 | €69,769,359 | €2,305,594 | €27,065,181 | — |
Sign in to download data
Source: German Commercial Register (Handelsregister) Darmstadt Local Court, HRB 88376 (as of 1 November 2026)
| Cost type | Amount | Share |
|---|---|---|
| Personnel Costs | €19,583,182 | 94.2% |
| Depreciation | €762,480 | 3.7% |
| Interest & Similar | €451,643 | 2.2% |
